97 related articles for article (PubMed ID: 24168387)
1. Very late relapse of PTLD 10 yr after allogeneic HSCT and nine yr after stopping immunosuppressive therapy.
Helgestad J; Rosthøj S; Pedersen MH; Johansen P; Iyer V; Østergaard E; Heilmann C
Pediatr Transplant; 2014 Feb; 18(1):E35-9. PubMed ID: 24168387
[TBL] [Abstract][Full Text] [Related]
2. [A clinical study of lymphoproliferative disorders following allogeneic hematopoietic stem cell transplantation].
Xu LP; Huang XJ; Liu DH; Chen YH; Shi HX; Chen DB
Zhonghua Nei Ke Za Zhi; 2007 Dec; 46(12):996-9. PubMed ID: 18478915
[TBL] [Abstract][Full Text] [Related]
3. [Epstein-Barr virus-associated post-transplant lymphoproliferative disorder diagnosed by the episode of intestinal perforation following allogeneic hematopoietic stem cell transplantation].
Aimoto M; Yamane T; Inoue A; Momose D; Moriguchi-Aimoto R; Wada-Inoue E; Okamoto S; Koh H; Nakane T; Takeoka Y; Akahori-Nakamae M; Nishiki-Kosaka S; Terada Y; Nakamae H; Koh KR; Nakao T; Ohsawa M; Hino M
Rinsho Ketsueki; 2010 Dec; 51(12):1775-80. PubMed ID: 21258188
[TBL] [Abstract][Full Text] [Related]
4. High incidence of PTLD after non-T-cell-depleted allogeneic haematopoietic stem cell transplantation as a consequence of intensive immunosuppressive treatment.
Juvonen E; Aalto SM; Tarkkanen J; Volin L; Mattila PS; Knuutila S; Ruutu T; Hedman K
Bone Marrow Transplant; 2003 Jul; 32(1):97-102. PubMed ID: 12815484
[TBL] [Abstract][Full Text] [Related]
5. Examining the origin of posttransplant lymphoproliferative disorder in a patient after a second allogeneic hematopoeitic stem cell transplantation for relapsed BCR-ABL positive acute lymphoblastic leukemia.
Ruf S; Moser O; Wössmann W; Kreyenberg H; Wagner HJ
J Pediatr Hematol Oncol; 2011 Jan; 33(1):50-4. PubMed ID: 21178708
[TBL] [Abstract][Full Text] [Related]
6. Unmanipulated donor lymphocytes for EBV-related PTLD after T-cell depleted HLA-haploidentical transplantation.
De Pasquale MD; Mastronuzzi A; De Vito R; Cometa A; Inserra A; Russo C; De Ioris MA; Locatelli F
Pediatrics; 2012 Jan; 129(1):e189-94. PubMed ID: 22144701
[TBL] [Abstract][Full Text] [Related]
7. Lymphoproliferative disorders following allogeneic bone marrow transplantation: the Vancouver experience.
Micallef IN; Chhanabhai M; Gascoyne RD; Shepherd JD; Fung HC; Nantel SH; Toze CL; Klingemann HG; Sutherland HJ; Hogge DE; Nevill TJ; Le A; Barnett MJ
Bone Marrow Transplant; 1998 Nov; 22(10):981-7. PubMed ID: 9849695
[TBL] [Abstract][Full Text] [Related]
8. Post-transplant lymphoproliferative disorders after live donor renal transplantation.
Jain M; Badwal S; Pandey R; Srivastava A; Sharma RK; Gupta RK
Clin Transplant; 2005 Oct; 19(5):668-73. PubMed ID: 16146560
[TBL] [Abstract][Full Text] [Related]
9. Complete immunosuppressive withdrawal as a uniform approach to post-transplant lymphoproliferative disease in pediatric liver transplantation.
Hurwitz M; Desai DM; Cox KL; Berquist WE; Esquivel CO; Millan MT
Pediatr Transplant; 2004 Jun; 8(3):267-72. PubMed ID: 15176965
[TBL] [Abstract][Full Text] [Related]
10. Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial.
Trappe R; Oertel S; Leblond V; Mollee P; Sender M; Reinke P; Neuhaus R; Lehmkuhl H; Horst HA; Salles G; Morschhauser F; Jaccard A; Lamy T; Leithäuser M; Zimmermann H; Anagnostopoulos I; Raphael M; Riess H; Choquet S; ;
Lancet Oncol; 2012 Feb; 13(2):196-206. PubMed ID: 22173060
[TBL] [Abstract][Full Text] [Related]
11. Response to rituximab-based therapy and risk factor analysis in Epstein Barr Virus-related lymphoproliferative disorder after hematopoietic stem cell transplant in children and adults: a study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation.
Styczynski J; Gil L; Tridello G; Ljungman P; Donnelly JP; van der Velden W; Omar H; Martino R; Halkes C; Faraci M; Theunissen K; Kalwak K; Hubacek P; Sica S; Nozzoli C; Fagioli F; Matthes S; Diaz MA; Migliavacca M; Balduzzi A; Tomaszewska A; Camara Rde L; van Biezen A; Hoek J; Iacobelli S; Einsele H; Cesaro S;
Clin Infect Dis; 2013 Sep; 57(6):794-802. PubMed ID: 23771985
[TBL] [Abstract][Full Text] [Related]
12. [Identification of acute lymphoctic leukemia extramedullary relapse and PTLD after allo-HSCT by monitoring sex chromosome chimeric status with FISH].
Du X; Liu QF; Zhang LS; Song LL; Fan ZP; Xu B; Sun J
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Apr; 26(2):147-50. PubMed ID: 19350504
[TBL] [Abstract][Full Text] [Related]
13. Post-transplantation lymphoproliferative disorder in pediatric kidney-transplant recipients - a national study.
Cleper R; Ben Shalom E; Landau D; Weissman I; Krause I; Konen O; Rahamimov R; Mor E; Bar-Nathan N; Frishberg Y; Davidovits M
Pediatr Transplant; 2012 Sep; 16(6):619-26. PubMed ID: 22708682
[TBL] [Abstract][Full Text] [Related]
14. Lymphoma after solid organ transplantation: risk, response to therapy, and survival at a transplantation center.
Knight JS; Tsodikov A; Cibrik DM; Ross CW; Kaminski MS; Blayney DW
J Clin Oncol; 2009 Jul; 27(20):3354-62. PubMed ID: 19451438
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus-associated pneumonia in patients with post-transplant lymphoproliferative disease after hematopoietic stem cell transplantation.
Liu QF; Fan ZP; Luo XD; Sun J; Zhang Y; Ding YQ
Transpl Infect Dis; 2010 Aug; 12(4):284-91. PubMed ID: 20345506
[TBL] [Abstract][Full Text] [Related]
16. Rituximab treatment for Epstein-Barr virus DNAemia after alternative-donor hematopoietic stem cell transplantation.
Coppoletta S; Tedone E; Galano B; Soracco M; Raiola AM; Lamparelli T; Gualandi F; Bregante S; Ibatici A; di Grazia C; Dominietto A; Varaldo R; Bruno B; Frassoni F; Van Lint MT; Bacigalupo A
Biol Blood Marrow Transplant; 2011 Jun; 17(6):901-7. PubMed ID: 20950702
[TBL] [Abstract][Full Text] [Related]
17. [Post transplant lymphoproliferative disorder (PTLD)--10 years follow-up].
Ignacak E; Betkowska-Prokop A; Kuźniewski M; Rudzki Z; Okoń K; Skotnicki A; Jurczak W; Kulig J; Czupryna A; Bucki J; Sułowicz W
Przegl Lek; 2011; 68(12):1202-3. PubMed ID: 22519281
[TBL] [Abstract][Full Text] [Related]
18. Post-transplant lymphoproliferative disease of donor origin, following haematopoietic stem cell transplantation in a patient with blastic plasmacytoid dendritic cell neoplasm.
Piccin A; Morello E; Svaldi M; Haferlach T; Facchetti F; Negri G; Vecchiato C; Fisogni S; Pusceddu I; Cortelazzo S
Hematol Oncol; 2012 Dec; 30(4):210-3. PubMed ID: 22915052
[TBL] [Abstract][Full Text] [Related]
19. [The efficacy and safety of donor lymphocyte infusion to treat Epstein-Barr virus associated lymphoproliferative diseases after allogeneic hematopoietic stem cell transplantation].
Xu LP; Liu DH; Liu KY; Chen H; Han W; Wang Y; Wang J; Shi HX; Huang XJ
Zhonghua Nei Ke Za Zhi; 2010 Nov; 49(11):955-8. PubMed ID: 21211211
[TBL] [Abstract][Full Text] [Related]
20. Low incidence of posttransplant lymphoproliferative disorder after allogeneic stem cell transplantation in patients with lymphoma treated with rituximab.
Fujimoto A; Hiramoto N; Yamasaki S; Inamoto Y; Ogata M; Sugio Y; Fukuda T; Uchida N; Ikegame K; Matsuoka KI; Shiratori S; Kondo T; Miyamoto T; Eto T; Ichinohe T; Kanda Y; Atsuta Y; Suzuki R;
Hematol Oncol; 2020 Apr; 38(2):146-152. PubMed ID: 31953867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
